The attenuation of NETs using Syk inhibitor, possibly through reduction of the downstream signaling of TLR-4 and Fc gamma receptors, was proposed as an interesting strategy for the treatment in lupus. This evidence concerns the gene TLR4 and systemic lupus erythematosus.